2025-10-30 - Analysis Report
Okay, here's an analysis of Albemarle Corp (ALB) based on the provided data.

**1. Performance vs. S&P 500 (VOO)**

*   **Ticker:** ALB
*   **Company:** Albemarle Corp (A specialty chemicals company, focusing on lithium, bromine specialties, and catalysts.)
*   **ALB Cumulative Return:** -3.41%
*   **VOO Cumulative Return:** 104.04%
*   **Spread:**
    *   Max Spread: 187.2
    *   Min Spread: -121.0
    *   Current Spread: -111.6
    *   Relative Spread: 3.0

**Analysis:**

ALB has significantly underperformed the S&P 500 (VOO).  The current spread of -111.6 indicates substantial underperformance. The relative spread of 3.0 suggests that ALB is near the lower end of its historical performance range compared to the S&P 500.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD   | Alpha   | Beta   | Cap(B) |
|------------|---------|-------|---------|--------|--------|
| 2015-2017  | 85.0%   | 68.0% | 56.0%   | 0.1    | 15.1   |
| 2016-2018  | 9.0%    | 68.0% | -6.0%   | 0.0    | 9.1    |
| 2017-2019  | -44.0%  | 73.9% | -66.0%  | 0.1    | 8.6    |
| 2018-2020  | 44.0%   | 79.4% | 20.0%   | 0.2    | 17.4   |
| 2019-2021  | 149.0%  | 79.4% | 103.0%  | -0.1   | 27.5   |
| 2020-2022  | 148.0%  | 79.9% | 149.0%  | 0.5    | 25.5   |
| 2021-2023  | -26.0%  | 81.9% | -27.0%  | 0.5    | 17.0   |
| 2022-2024  | -152.0% | 81.9% | -172.0% | 0.3    | 10.1   |
| 2023-2025  | -225.0% | 81.9% | -293.0% | -0.5   | 11.8   |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate shows significant volatility, with periods of very high growth (e.g., 2019-2021, 2020-2022) followed by steep declines (2022-2024, 2023-2025).  The recent trend is strongly negative.
*   **MDD:**  The Maximum Drawdown is consistently high, indicating substantial risk and potential for significant losses.
*   **Alpha:** The alpha values are highly variable, with periods of substantial outperformance (high positive alpha) followed by significant underperformance (large negative alpha).  The recent alpha is extremely negative, suggesting ALB is significantly underperforming its benchmark.
*   **Beta:** The beta values are generally low, suggesting that ALB is not highly correlated with the overall market.  However, the beta has fluctuated, even turning negative in one period.

**2. Recent Stock Price Movements**

*   **Current Price:** 100.06
*   **Previous Close:** 96.68
*   **Change:** 3.5 (Increase)
*   **5-day Moving Average:** 98.112
*   **20-day Moving Average:** 93.552
*   **60-day Moving Average:** 84.3342

**Analysis:**

The stock price has increased recently (change of 3.5). The current price is above the 5-day, 20-day, and 60-day moving averages, suggesting a short-term upward trend.

**3. Market Risk Indicator (MRI) and Other Indicators**

*   **MRI:** 0.9 (Medium Investment Recommended)
*   **RSI:** 58.09 (Neutral)
*   **PPO:** 0.2078
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (12 shares - Very Safe - MRI:0.90) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-10-01)
*   **Recent Change in Relative Spread (20 days):** -2.5 (Negative - Short-term decline)
*   **Expected Return (%):** 918.8%

**Analysis:**

*   **MRI:** A medium investment recommendation suggests moderate risk, balancing potential returns and downside.
*   **RSI:**  An RSI of 58.09 is generally considered neutral, neither overbought nor oversold.
*   **PPO:** the PPO is a momentum oscillator that measures the difference between two moving averages, divided by the longer moving average
*   **Hybrid Signal:** The hybrid signal recommends using all available cash to buy shares, suggesting a bullish outlook, despite the other concerning indicators.
*   **Change in Relative Spread:** The negative change in relative spread indicates that the stock's underperformance compared to the S&P 500 has worsened recently.
*   **Expected Return:** The extremely high expected return (918.8%) should be viewed with skepticism.  It likely represents a very optimistic scenario based on potential long-term growth, but it needs to be balanced against the significant risks highlighted by other indicators.
*   **Price Change:** The recent price change of 3.5 suggests a potential short-term rebound.

**4. Recent News & Significant Events**

*   **Negative Earnings Prediction:** Several articles highlight concerns about Albemarle's earnings, with some predicting negative earnings reports.
*   **Lithium Momentum:** Some reports suggest a potential recovery in lithium prices, which could benefit Albemarle.
*   **Analyst Report:** Morningstar has an analyst report, which could provide a more in-depth analysis.
*   **Market Wrap:**  Albemarle was mentioned in a daily market wrap, indicating it's on investors' radar.
*   **Stock Slides:**  One article noted that Albemarle's stock slid even as the market rose, suggesting company-specific issues.

**Analysis:**

The news is mixed.  The negative earnings predictions and articles about the stock "sliding" are concerning. However, the potential recovery in lithium prices offers a glimmer of hope.

**4-2. Analyst Opinions**

*   **Consensus:** Hold
*   **Mean Rating:** 2.65 (~Hold)
*   **Number of Opinions:** 23
*   **Target Price:**
    *   Average: 96.45
    *   High: 200.00
    *   Low: 58.00

**Analysis:**

The analyst consensus is "Hold," indicating a neutral outlook. The average target price is below the current price, suggesting limited upside potential. The wide range between the high and low target prices reflects significant uncertainty about the stock's future.

**5. Recent Earnings Analysis**

| 날짜       | EPS   | 매출     |
|------------|-------|----------|
| 2025-08-04 | -0.16 | 1.33 B$  |
| 2025-04-30 | 0     | 1.08 B$  |
| 2024-11-06 | -9.45 | 1.35 B$  |
| 2024-07-31 | -1.96 | 1.43 B$  |
| 2025-08-04 | -1.96 | 1.43 B$  |

**Analysis:**

The recent EPS figures are concerning, showing losses in several quarters, including a significant loss in 2024-11-06. While revenue has fluctuated, it doesn't seem to be translating into profitability.

**6. Financial Information**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-06-30   | $1.33B    | 14.80%        |
| 2025-03-31   | $1.08B    | 14.51%        |
| 2024-12-31   | $1.23B    | 11.22%        |
| 2024-09-30   | $1.35B    | -7.68%        |
| 2024-06-30   | $1.43B    | -0.74%        |

| Quarter      | Equity    | ROE       |
|--------------|-----------|-----------|
| 2025-06-30   | $10.24B   | 0.22%     |
| 2025-03-31   | $10.03B   | 0.41%     |
| 2024-12-31   | $9.96B    | 0.76%     |
| 2024-09-30   | $10.24B   | -10.44%   |
| 2024-06-30   | $11.22B   | -1.68%    |

**Analysis:**

*   **Revenue and Profit Margin:** The profit margin has been volatile, with negative margins in some quarters. While revenue has been relatively stable, it hasn't consistently translated into profits.
*   **Equity and ROE:** The ROE has also been highly variable, with significant negative values in some quarters. This indicates that the company is not efficiently generating profits from its equity.

**7. Overall Summary**

Albemarle Corp (ALB) presents a mixed picture. The company has significantly underperformed the S&P 500. Recent earnings reports show losses, and analyst opinions are neutral ("Hold"). However, there are some positive signs, such as a recent increase in stock price and potential recovery in lithium prices. The extremely high expected return should be viewed cautiously, given the risks highlighted by other indicators. The recent price change of 3.5 suggests a potential short-term rebound.

**Recommendation:**

Based on the provided data, a cautious approach is warranted. The stock carries significant risk, and further investigation is recommended before making any investment decisions. Monitor the company's upcoming earnings reports, lithium market trends, and any analyst updates.
